| __timestamp | Pharming Group N.V. | Soleno Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 14182353 | 2242216 |
| Thursday, January 1, 2015 | 15503028 | 4536244 |
| Friday, January 1, 2016 | 16183585 | 5184803 |
| Sunday, January 1, 2017 | 22382849 | 3068742 |
| Monday, January 1, 2018 | 33038206 | 7178000 |
| Tuesday, January 1, 2019 | 31777040 | 16267000 |
| Wednesday, January 1, 2020 | 41464134 | 23191000 |
| Friday, January 1, 2021 | 67178053 | 21453000 |
| Saturday, January 1, 2022 | 52531000 | 15265000 |
| Sunday, January 1, 2023 | 68914000 | 25189000 |
Igniting the spark of knowledge
In the competitive landscape of biotechnology, strategic investment in research and development (R&D) is crucial. Over the past decade, Pharming Group N.V. and Soleno Therapeutics, Inc. have demonstrated contrasting approaches to R&D spending. From 2014 to 2023, Pharming Group N.V. has consistently increased its R&D budget, peaking in 2023 with a 386% increase from its 2014 spending. This commitment underscores their focus on innovation and long-term growth. In contrast, Soleno Therapeutics, Inc. has shown a more volatile R&D expenditure pattern, with a notable spike in 2020, reaching 10 times its 2014 level, before stabilizing. This fluctuation reflects a strategic pivot, possibly driven by specific project needs or market conditions. As the biotech sector evolves, these spending patterns highlight the diverse strategies companies employ to maintain a competitive edge.
Eli Lilly and Company or Soleno Therapeutics, Inc.: Who Invests More in Innovation?
Comparing Innovation Spending: Johnson & Johnson and Pharming Group N.V.
Incyte Corporation vs Soleno Therapeutics, Inc.: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for Dr. Reddy's Laboratories Limited and Soleno Therapeutics, Inc.
Comparing Innovation Spending: BioMarin Pharmaceutical Inc. and Soleno Therapeutics, Inc.
Blueprint Medicines Corporation vs Soleno Therapeutics, Inc.: Strategic Focus on R&D Spending
Pharming Group N.V. or Grifols, S.A.: Who Invests More in Innovation?
Research and Development Investment: Pharming Group N.V. vs Alkermes plc
R&D Insights: How Pharming Group N.V. and Corcept Therapeutics Incorporated Allocate Funds
R&D Insights: How Pharming Group N.V. and MannKind Corporation Allocate Funds
Comparing Innovation Spending: Pharming Group N.V. and Novavax, Inc.
Research and Development: Comparing Key Metrics for Xenon Pharmaceuticals Inc. and Soleno Therapeutics, Inc.